Nebigil CG - Search Results

1

Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis.

Chouha N, Abou-Hamdan H, Yurugi H, Yoshii R, Ii H, Najem A, Ghanem GE, Nakata S, Rajalingam K, Peng Y, Wang D, Nebigil CG, Désaubry L. Chouha N, et al. Among authors: nebigil cg. Eur J Med Chem. 2022 Nov 15;242:114635. doi: 10.1016/j.ejmech.2022.114635. Epub 2022 Aug 4. Eur J Med Chem. 2022. PMID: 35988448 Free article.

2

Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases.

Wang D, Tabti R, Elderwish S, Abou-Hamdan H, Djehal A, Yu P, Yurugi H, Rajalingam K, Nebigil CG, Désaubry L. Wang D, et al. Among authors: nebigil cg. Cell Mol Life Sci. 2020 Sep;77(18):3525-3546. doi: 10.1007/s00018-020-03475-1. Epub 2020 Feb 15. Cell Mol Life Sci. 2020. PMID: 32062751 Free PMC article. Review.

3

Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells.

Djehal A, Krayem M, Najem A, Hammoud H, Cresteil T, Nebigil CG, Wang D, Yu P, Bentouhami E, Ghanem GE, Désaubry L. Djehal A, et al. Among authors: nebigil cg. Eur J Med Chem. 2018 Jul 15;155:880-888. doi: 10.1016/j.ejmech.2018.06.052. Epub 2018 Jun 23. Eur J Med Chem. 2018. PMID: 29960207

4

Discovery of 3,3'-pyrrolidinyl-spirooxindoles as cardioprotectant prohibitin ligands.

Elderwish S, Audebrand A, Nebigil CG, Désaubry L. Elderwish S, et al. Among authors: nebigil cg. Eur J Med Chem. 2020 Jan 15;186:111859. doi: 10.1016/j.ejmech.2019.111859. Epub 2019 Nov 9. Eur J Med Chem. 2020. PMID: 31735574

5

Prohibitin ligands in cell death and survival: mode of action and therapeutic potential.

Thuaud F, Ribeiro N, Nebigil CG, Désaubry L. Thuaud F, et al. Among authors: nebigil cg. Chem Biol. 2013 Mar 21;20(3):316-31. doi: 10.1016/j.chembiol.2013.02.006. Chem Biol. 2013. PMID: 23521790 Free PMC article. Review.

6

Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses.

Nebigil CG, Moog C, Vagner S, Benkirane-Jessel N, Smith DR, Désaubry L. Nebigil CG, et al. Eur J Med Chem. 2020 Oct 1;203:112653. doi: 10.1016/j.ejmech.2020.112653. Epub 2020 Jul 15. Eur J Med Chem. 2020. PMID: 32693294 Free PMC article. Review.

7

SFPH proteins as therapeutic targets for a myriad of diseases.

Wang D, Tabti R, Elderwish S, Djehal A, Chouha N, Pinot F, Yu P, Nebigil CG, Désaubry L. Wang D, et al. Among authors: nebigil cg. Bioorg Med Chem Lett. 2020 Nov 15;30(22):127600. doi: 10.1016/j.bmcl.2020.127600. Epub 2020 Oct 6. Bioorg Med Chem Lett. 2020. PMID: 33035678 Free PMC article. Review.

8

Recent advances in the biology and chemistry of the flavaglines.

Ribeiro N, Thuaud F, Nebigil C, Désaubry L. Ribeiro N, et al. Bioorg Med Chem. 2012 Mar 15;20(6):1857-64. doi: 10.1016/j.bmc.2011.10.048. Epub 2011 Oct 20. Bioorg Med Chem. 2012. PMID: 22071525 Review.

9

Flavaglines as potent anticancer and cytoprotective agents.

Ribeiro N, Thuaud F, Bernard Y, Gaiddon C, Cresteil T, Hild A, Hirsch EC, Michel PP, Nebigil CG, Désaubry L. Ribeiro N, et al. Among authors: nebigil cg. J Med Chem. 2012 Nov 26;55(22):10064-73. doi: 10.1021/jm301201z. Epub 2012 Oct 23. J Med Chem. 2012. PMID: 23072299

10

FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity.

Qureshi R, Yildirim O, Gasser A, Basmadjian C, Zhao Q, Wilmet JP, Désaubry L, Nebigil CG. Qureshi R, et al. Among authors: nebigil cg. PLoS One. 2015 Nov 4;10(11):e0141826. doi: 10.1371/journal.pone.0141826. eCollection 2015. PLoS One. 2015. PMID: 26536361 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page